IL17A and age-related macular degeneration: Next, we investigated the effects of Humanin G and discovered that treatment with Humanin G reduced IL-17A protein levels by 48.31 % in AMD RPE cybrid cells, thereby highlighting the ability of Humanin G to suppress IL-17-mediated retinal inflammation.